Literature DB >> 6400136

Antithrombotic assessment and clinical potential of prostacyclin analogues.

B J Whittle, S Moncada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6400136     DOI： 10.1016/s0079-6468(08)70411-9

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  4 in total

1.  Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.

Authors:  R A Armstrong; R A Lawrence; R L Jones; N H Wilson; A Collier
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.

Authors:  J E Merritt; T J Hallam; A M Brown; I Boyfield; D G Cooper; D M Hickey; A A Jaxa-Chamiec; A J Kaumann; M Keen; E Kelly
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.

Authors:  J E Merritt; A M Brown; S Bund; D G Cooper; J W Egan; T J Hallam; A M Heagerty; D M Hickey; A J Kaumann; M Keen
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.

Authors:  A Corsini; G C Folco; R Fumagalli; S Nicosia; M A Noe; D Oliva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.